ARTICLE | Company News
Tensha Therapeutics, Roche deal
January 18, 2016 8:00 AM UTC
Roche will acquire Tensha for $115 million in cash plus up to $420 million in undisclosed clinical and regulatory milestones. Tensha’s TEN-010, a small molecule bromodomain inhibitor that is selectiv...